Cassia, LLC was founded in 2004 as a privately held biotechnology company and CRO/CMO specializing in green chemo-enzymatic synthesis solutions for preparing stable-isotope (D, C-13, N-15, O-17/18) labeled metabolites, proteins, nucleic acids, glycans, analogs, probes, and standards.